Kiniksa Pharmaceuticals International, plc Current Liabilities
Kiniksa Pharmaceuticals International, plc (KNSA) had Current Liabilities of $156.61 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-04-28
- 2026-03-31: Liabilities, Current $156.61M.
- 2025-12-31: Liabilities, Current $139.18M.
- 2025-09-30: Liabilities, Current $123.59M.
- 2025-06-30: Liabilities, Current $117.83M.
| Period end | Liabilities, Current |
|---|---|
| 2026-03-31 | $156.61M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $139.18M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $123.59M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $117.83M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $97.27M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $100.62M 10-K · filed 2026-02-24 |
| 2024-09-30 | $95.95M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $84.29M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $64.21M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $63.67M 10-K · filed 2025-02-25 |
| 2023-09-30 | $53.47M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $47.47M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $36.59M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $47.07M 10-K · filed 2024-02-28 |
| 2022-09-30 | $56.49M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $43.54M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $50.35M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $44.82M 10-K · filed 2023-03-02 |
| 2021-09-30 | $34.43M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $38.78M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $35.45M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $31.85M 10-K · filed 2022-02-24 |
| 2020-09-30 | $24.89M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $20.55M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $19.34M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $27.83M 10-K · filed 2021-02-25 |
| 2019-09-30 | $27.56M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $30.18M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $36.89M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $42.55M 10-K · filed 2020-03-05 |
| 2018-09-30 | $28.02M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $23.14M 10-Q · filed 2018-08-06 |
| 2017-12-31 | $17.43M 10-K · filed 2019-03-12 |